Literature DB >> 10560900

Treatment guidelines for geriatric mood disorders.

A Oshima1, T Higuchi.   

Abstract

The authors reviewed the literature on the pharmacotherapy of geriatric mood disorders. Based on the evidence available, we have proposed: (i) that although any antidepressant is assumedly equal in antidepressive efficacy, ones with weak anticholinergic and antialpha1 effects are preferable in geriatric patients; (ii) that augmentation therapy with lithium and methylphenidate has modest evidence of efficacy in this population; (iii) that modified electroconvulsive therapy is safe and effective for severe and psychotic depression in the elderly; and (iv) that lithium remains the first choice for geriatric bipolar disorder, although its optimal serum level may be lower than in younger adults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560900

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  4 in total

Review 1.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

Review 2.  Managing bipolar disorder in the elderly: defining the role of the newer agents.

Authors:  Martha Sajatovic; Subramoniam Madhusoodanan; Nicoleta Coconcea
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Electroconvulsive therapy and its different indications.

Authors:  Thomas C Baghai; Hans-Jürgen Möller
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

4.  A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch.

Authors:  Kamal Patel; Ashley Collins; Suzanne Holroyd; Andre Benja Lamyaithong
Journal:  Case Rep Psychiatry       Date:  2019-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.